AU2011346906B2 - Methods and compounds for detecting cancer - Google Patents

Methods and compounds for detecting cancer Download PDF

Info

Publication number
AU2011346906B2
AU2011346906B2 AU2011346906A AU2011346906A AU2011346906B2 AU 2011346906 B2 AU2011346906 B2 AU 2011346906B2 AU 2011346906 A AU2011346906 A AU 2011346906A AU 2011346906 A AU2011346906 A AU 2011346906A AU 2011346906 B2 AU2011346906 B2 AU 2011346906B2
Authority
AU
Australia
Prior art keywords
alkyl
compound
general formula
moiety
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011346906A
Other languages
English (en)
Other versions
AU2011346906A1 (en
Inventor
Mohammed Jaffar
Richard Knox
Ian Weeks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College Cardiff Consultants Ltd
Original Assignee
University College Cardiff Consultants Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College Cardiff Consultants Ltd filed Critical University College Cardiff Consultants Ltd
Publication of AU2011346906A1 publication Critical patent/AU2011346906A1/en
Application granted granted Critical
Publication of AU2011346906B2 publication Critical patent/AU2011346906B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/90209—Oxidoreductases (1.) acting on NADH or NADPH (1.6), e.g. those with a heme protein as acceptor (1.6.2) (general), Cytochrome-b5 reductase (1.6.2.2) or NADPH-cytochrome P450 reductase (1.6.2.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU2011346906A 2010-12-20 2011-12-08 Methods and compounds for detecting cancer Ceased AU2011346906B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1021494.8 2010-12-20
GBGB1021494.8A GB201021494D0 (en) 2010-12-20 2010-12-20 Compounds
PCT/GB2011/052430 WO2012085532A2 (en) 2010-12-20 2011-12-08 Methods and compounds for detecting cancer

Publications (2)

Publication Number Publication Date
AU2011346906A1 AU2011346906A1 (en) 2013-07-04
AU2011346906B2 true AU2011346906B2 (en) 2016-03-03

Family

ID=43598602

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011346906A Ceased AU2011346906B2 (en) 2010-12-20 2011-12-08 Methods and compounds for detecting cancer

Country Status (11)

Country Link
US (1) US20140370520A1 (https=)
EP (1) EP2655653B1 (https=)
CN (1) CN103492586A (https=)
AU (1) AU2011346906B2 (https=)
BR (1) BR112013015394A2 (https=)
CA (1) CA2822369A1 (https=)
DK (1) DK2655653T3 (https=)
ES (1) ES2563097T3 (https=)
GB (1) GB201021494D0 (https=)
IN (1) IN2013MN01107A (https=)
WO (1) WO2012085532A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201810152T4 (tr) * 2011-10-14 2018-08-27 The Board Of Regents Of The Universty Of Texas System Bileşikler ve anti-tümör nqo1 substratları.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100047839A1 (en) * 2008-08-19 2010-02-25 National Taipei University Of Technology Latent fluorimetric indicator for biological analytes determination and the preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005536517A (ja) * 2002-07-23 2005-12-02 スミスクライン ビーチャム コーポレーション キナーゼインヒビターとしてのピラゾロピリミジン
DE10303265A1 (de) * 2003-01-28 2004-07-29 Roche Diagnostics Gmbh Fluorimetrische Bestimmung von Analyten durch ein intramolekulares Quencher-Fluorophor-Konjugat
JP2009526085A (ja) * 2006-02-09 2009-07-16 スペクトラム ファーマシューティカルズ インコーポレイテッド Ｅｏ９およびプロピレングリコールの使用による膀胱癌の治療
US20090012031A1 (en) * 2007-07-03 2009-01-08 The Regents Of The University Of Michigan EZH2 Cancer Markers
WO2011113018A1 (en) * 2010-03-12 2011-09-15 Ampere Life Sciences, Inc. Measurement and control of biological time

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100047839A1 (en) * 2008-08-19 2010-02-25 National Taipei University Of Technology Latent fluorimetric indicator for biological analytes determination and the preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HERNICK, M. et al., Journal of Medicinal Chemistry. 2002, vol. 45, pages 3540-3548 *
HUANG, S-T. et al., Biosensors and Bioelectronics. 2008, vol. 23, pages 1793-1798 *
SMITSKAMP-WILMS, E. et al., Biochemical Pharmacology. 1994, vol. 47, pages 1325-1332 *
VOLPATO, M. et al., Molecular Cancer Therapeutics. 2007, vol. 6, pages 3122-3130 *

Also Published As

Publication number Publication date
EP2655653B1 (en) 2015-11-18
BR112013015394A2 (pt) 2016-09-20
IN2013MN01107A (https=) 2015-06-12
AU2011346906A1 (en) 2013-07-04
CA2822369A1 (en) 2012-06-28
EP2655653A2 (en) 2013-10-30
US20140370520A1 (en) 2014-12-18
DK2655653T3 (da) 2016-02-22
ES2563097T3 (es) 2016-03-10
WO2012085532A2 (en) 2012-06-28
GB201021494D0 (en) 2011-02-02
HK1191062A1 (zh) 2014-07-18
CN103492586A (zh) 2014-01-01
WO2012085532A3 (en) 2012-08-16

Similar Documents

Publication Publication Date Title
US6919463B2 (en) Signalling compounds for use in methods of detecting hydrogen peroxide
EP0544662B1 (en) Enzyme amplified lanthanide chelate luminescence assay
EP0635006B1 (en) Europium and terbium chelators for time-resolved fluorometric assays
Li et al. Ratiometric fluorescent probe based on ESIPT for the highly selective detection of cysteine in living cells
JP4672144B2 (ja) 近赤外化学発光性アクリジニウム化合物およびその使用。
US20100136592A1 (en) Photo-Induced Damage Mitigating Agents and Preparation and Methods of Use Thereof
Li et al. Aggregation-induced emission fluorescent probe for monitoring endogenous alkaline phosphatase in living cells
JP2010237226A (ja) 化学発光性アクリジニウム化合物を使用するヒドリドの測定
CN110606859B (zh) 聚集诱导发光化合物、其制备方法及其检测病毒的应用
JP2732501B2 (ja) β―ガラクトシダーゼのための基質
KR20210043584A (ko) 규소로 치환된 로다민 염료 및 염료 접합체
CA2342600A1 (en) Xanthan-ester and acridan substrates for horseradish peroxidase
CN114149448B (zh) 一种用于检测硝基还原酶的近红外荧光探针及应用
AU2011346906B2 (en) Methods and compounds for detecting cancer
Chen et al. In situ Cu2+-triggered wavelength-tunable fluorescent sensor for highly sensitive sensing inorganic pyrophosphatase activity and its logic gate application
CN113637048A (zh) 一种γ-谷氨酰转肽酶的双光子荧光探针及其制备方法和应用
HK1191062B (en) Methods and compounds for detecting cancer
JPH04338398A (ja) ジフェニルメタン誘導体類、その製造方法およびそれを含有するヨードチロニン類を結合する蛋白からヨードチロニン類を置換するための試薬
JPH05346400A (ja) 改良された化学ルミネセント試薬および方法
JP5044779B2 (ja) フェノールフタレイン誘導体および生体内ポリアミン検出用検査薬
JP2007504119A (ja) 化学発光化合物
JP4704572B2 (ja) 永久蛍光アッセイ法
KR20260040745A (ko) Cox 검출용 형광 프로브 및 이의 제조방법
CN121202831A (zh) 一种具有大斯托克斯位移的半胱氨酸荧光探针、方法和应用
JP3692265B2 (ja) 化学発光試薬の製造方法

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired